UnitedHealth Group Stock Surges on Q2 Earnings Beat and Raised Guidance

UnitedHealth Group's stock price has been on the rise after the company reported a strong second-quarter earnings beat and raised its full-year guidance. In Q2 2026, UnitedHealth delivered adjusted EPS of $6.38 on revenue of $112.03 billion, exceeding analyst estimates.

The company's healthcare plans and services business saw significant growth, with revenue up from the prior year. The medical care ratio, a key profitability metric for managed-care companies, improved to 86.7% from 89.4% a year earlier, driven by lower medical costs relative to premiums.

Medicare Advantage was cited as a main driver of the quarter's performance, with costs coming in below expectations and supporting margins in the core insurance operations. The strong results prompted analyst price target increases, with Bank of America raising its target to $512 per share and Morgan Stanley lifting its target to $529.

UnitedHealth Group's market capitalization stands at INR 32.512 trillion as of September 12, 2026, placing it among the world's largest listed companies by value. While sector-wide concerns about healthcare policy, reimbursement, and utilization may weigh on valuations, management remains confident in its ability to navigate these challenges.